Literature DB >> 32798011

Can SARS-CoV-2 be a Risk Factor for Pulmonary Aspergillosis?

Marta García Clemente1, Tamara Hermida Valverde2, Oihana Leizaola-Irigoyen3, Ana Isabel Enríquez Rodríguez2, Miguel Arias Guillén2, Mauricio Telenti Asensio4, Enrique García Carus4, Teresa Peláez García5.   

Abstract

Year:  2020        PMID： 32798011      PMCID： PMC7833498          DOI： 10.1016/j.arbres.2020.06.028

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN： 0300-2896            Impact factor:   4.872


× No keyword cloud information.
  14 in total

1.  Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients.

Authors:  Carolina Garcia-Vidal; Pere Barba; Montse Arnan; Asunción Moreno; Isabel Ruiz-Camps; Carlota Gudiol; Josefina Ayats; Guillermo Ortí; Jordi Carratalà
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

2.  Invasive Aspergillosis as a Complication of Influenza Virus H3N2 Infection.

Authors:  Marta García Clemente; Lorena Martín Iglesias; Ana Isabel Enríquez Rodríguez; Marta Iscar Urrutia; Claudia Madrid Carbajal; Francisco Julián López González
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2020-02-22       Impact factor: 4.872

3.  Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.

Authors:  Alexander F A D Schauwvlieghe; Bart J A Rijnders; Nele Philips; Rosanne Verwijs; Lore Vanderbeke; Carla Van Tienen; Katrien Lagrou; Paul E Verweij; Frank L Van de Veerdonk; Diederik Gommers; Peter Spronk; Dennis C J J Bergmans; Astrid Hoedemaekers; Eleni-Rosalina Andrinopoulou; Charlotte H S B van den Berg; Nicole P Juffermans; Casper J Hodiamont; Alieke G Vonk; Pieter Depuydt; Jerina Boelens; Joost Wauters
Journal:  Lancet Respir Med       Date:  2018-07-31       Impact factor: 30.700

4.  Clinical and immunological features of severe and moderate coronavirus disease 2019.

Authors:  Guang Chen; Di Wu; Wei Guo; Yong Cao; Da Huang; Hongwu Wang; Tao Wang; Xiaoyun Zhang; Huilong Chen; Haijing Yu; Xiaoping Zhang; Minxia Zhang; Shiji Wu; Jianxin Song; Tao Chen; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

5.  Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.

Authors:  Marion Blaize; Julien Mayaux; Cécile Nabet; Alexandre Lampros; Anne-Geneviève Marcelin; Marc Thellier; Renaud Piarroux; Alexandre Demoule; Arnaud Fekkar
Journal:  Emerg Infect Dis       Date:  2020-06-21       Impact factor: 6.883

6.  Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study.

Authors:  Joost Wauters; Ingrid Baar; Philippe Meersseman; Wouter Meersseman; Karolien Dams; Rudi De Paep; Katrien Lagrou; Alexander Wilmer; Philippe Jorens; Greet Hermans
Journal:  Intensive Care Med       Date:  2012-08-16       Impact factor: 17.440

7.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

8.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

Review 9.  Coronavirus disease 2019: What we know?

Authors:  Feng He; Yu Deng; Weina Li
Journal:  J Med Virol       Date:  2020-03-28       Impact factor: 20.693

10.  COVID-19 associated pulmonary aspergillosis.

Authors:  Philipp Koehler; Oliver A Cornely; Bernd W Böttiger; Fabian Dusse; Dennis A Eichenauer; Frieder Fuchs; Michael Hallek; Norma Jung; Florian Klein; Thorsten Persigehl; Jan Rybniker; Matthias Kochanek; Boris Böll; Alexander Shimabukuro-Vornhagen
Journal:  Mycoses       Date:  2020-05-15       Impact factor: 4.377
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.